Cite
HARVARD Citation
Vivaldi, C. et al. (n.d.). P-159Analysis of early tumor shrinkage and depth of response in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX or gemcitabine + nab-paclitaxel. Annals of oncology. p. . [Online].